Approvals/TGA/FLUBLOK trivalent recombinant influenza vaccine, Influenza haemagglutinin recombinant 135 mcg, 0.5 mL solution for injection syringe

Approved

STANDARD

FLUBLOK trivalent recombinant influenza vaccine, Influenza haemagglutinin recombinant 135 mcg, 0.5 mL solution for injection syringe

Sanofi-Aventis Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 4d380ffcd9e39a1a
Product Name: FLUBLOK trivalent recombinant influenza vaccine, Influenza haemagglutinin recombinant 135 mcg, 0.5 mL solution for injection syringe
Artg Id: 446791
Artg Name: FLUBLOK trivalent recombinant influenza vaccine, Influenza haemagglutinin recombinant 135 mcg, 0.5 mL solution for injection syringe
Sponsor: Sanofi-Aventis Australia Pty Ltd
Company Detail Path: /organization/sanofi-aventis-australia-pty-ltd
Artg Date: 2025-05-09
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/40f98ae2be78173d07ad907ae7e94a0a.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 29, 2025

Approval ID

4d380ffcd9e39a1a

Type

Standard